Log In
Print this Print this

Azopt, brinzolamide

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionCarbonic anhydrase II (CAII) inhibitor formulated for multidose topical ophthalmic use
Molecular Target Carbonic anhydrase II (CAII)
Mechanism of ActionCarbonic anhydrase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat elevated intraocular pressure (IOP)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today